| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/04/2006 | CN1277582C Method for removing endotoxin from influenza vaccine formulation |
| 10/03/2006 | US7115374 kit with oligonucleotide amplification primers for detecting very low levels of West Nile virus nucleic acids |
| 10/03/2006 | US7115363 Retrovirus capable of causing AIDS, means and methods for detecting it in vitro |
| 10/03/2006 | US7115270 Smallpox vaccine |
| 09/28/2006 | WO2006101841A2 Seneca valley virus based compositions and methods for treating disease |
| 09/28/2006 | WO2006100060A2 Colloidal nanocomposites comprising lbl-particles, lipids and biological components and method for the production thereof |
| 09/28/2006 | WO2006078975A3 Improved vaccine against feline calicivirus |
| 09/28/2006 | WO2006051545A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/28/2006 | WO2005072214A3 Improved inactivated fcv vaccines |
| 09/28/2006 | US20060216702 Virus-like particles, methods of preparation, and immunogenic compositions |
| 09/28/2006 | US20060216700 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 09/28/2006 | US20060216312 Mutants of replication competent vaccinia virus |
| 09/28/2006 | US20060216311 Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA |
| 09/28/2006 | US20060216310 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | CA2602676A1 Seneca valley virus based compositions and methods for treating disease |
| 09/27/2006 | EP1705183A1 Binding molecules for human factor VIII and factor VIII-like proteins |
| 09/27/2006 | CN1839201A Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 09/27/2006 | CN1839200A A recombinant virus comprising BPI gene and a pharmaceutical composition containing the same and uses thereof |
| 09/27/2006 | CN1837359A Method for eliminating virus activity from biological material |
| 09/26/2006 | US7112439 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 09/26/2006 | US7112435 Phage constructs used to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with the coat protein in a regulated manner. |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/21/2006 | WO2006099592A2 Mannose immunogens for hiv-1 |
| 09/21/2006 | WO2006099360A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 09/21/2006 | WO2006097285A1 Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 09/21/2006 | WO2006097284A1 Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
| 09/21/2006 | WO2006096985A1 Human endogenous retrovirus with foamy-like properties and uses thereof |
| 09/21/2006 | US20060211115 Methods of generating chimeric adenoviruses and uses for such chimeric aden oviruses |
| 09/21/2006 | US20060210969 used in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis; drug screening |
| 09/21/2006 | US20060210965 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 09/21/2006 | US20060210587 Virus-like particles for the induction of autoantibodies |
| 09/21/2006 | CA2673395A1 Human endogenous retrovirus with foamy-like properties and uses thereof |
| 09/21/2006 | CA2601797A1 Mannose immunogens for hiv-1 |
| 09/21/2006 | CA2600690A1 Recombinant e-selectin made in insect cells |
| 09/21/2006 | CA2600484A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 09/20/2006 | EP1701738A2 Methods for porducing storage stable viruses and immunogenic compositions thereof |
| 09/19/2006 | US7109029 Adenoviral transcription of colony stimulating factor; gene expression inhibition; antitumor agents; antiproliferative agents; tissue engineering |
| 09/19/2006 | US7109025 Viral vectors and viral vaccines based on recombinant porcine adenoviruses |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/18/2006 | CA2501301A1 Human endogenous foamy retrovirus and uses thereof |
| 09/14/2006 | WO2006096459A2 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | WO2006095431A1 Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine |
| 09/14/2006 | WO2006094756A2 Varicella zoster virus vaccine |
| 09/14/2006 | WO2006094385A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 09/14/2006 | WO2006052813A3 Stable and filterable enveloped virus formulations |
| 09/14/2006 | WO2004075836A3 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060204523 Flavivirus vaccine delivery system |
| 09/14/2006 | US20060204519 Genetic vaccine for generating immunity to human immunodeficiency virus-1 |
| 09/14/2006 | US20060204477 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 09/14/2006 | CA2603711A1 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | CA2600905A1 Varicella zoster virus vaccine |
| 09/14/2006 | CA2600675A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 09/13/2006 | EP1700911A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| 09/13/2006 | EP1699919A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 09/13/2006 | EP1699918A1 High-titer retroviral packaging cells |
| 09/13/2006 | EP1699481A2 Methods and compositions comprising bacteriophage nanoparticles |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP0843732B1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 09/13/2006 | CN1833027A Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 09/13/2006 | CN1833024A Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto |
| 09/13/2006 | CN1831122A Reproduction of defect type Tiantan strain vaccinia virus |
| 09/13/2006 | CN1274821C Modular transport systems for molecular substances and production and use thereof |
| 09/12/2006 | US7105165 Mutant human hepatitis B viral strain and uses thereof |
| 09/08/2006 | CA2573392A1 Methods of detecting a phenotype of a polymorphic protein |
| 09/07/2006 | US20060198855 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 09/07/2006 | US20060198853 Papilloma virus capsomere vaccine formulations and methods of use |
| 09/07/2006 | DE102005008765A1 Kontrastmittel auf der Basis von Bakteriophagen, Verwendung und Verfahren zu deren Herstellung Contrast agents based on bacteriophages, use and process for their preparation |
| 09/06/2006 | EP1697529A1 Viral particles containing an alpha virus derived vector and method for preparing said viral particle |
| 09/06/2006 | EP1697521A2 Multi plasmid system for the production of influenza virus |
| 09/06/2006 | EP1697511A2 Immunotherapy compositions, method of making and method of use thereof |
| 09/06/2006 | EP1697507A1 Use of proteins and peptides coded by the genome of a novel strain of sars-associated coronavirus |
| 09/06/2006 | EP1697505A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 09/06/2006 | EP0981601B1 Methods for cultivating cells and propagating viruses |
| 09/06/2006 | CN1829799A Recombinant influenza vectors with a POLII promoter and ribozymes |
| 09/06/2006 | CN1829796A Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cDNA therefrom, and use thereof |
| 09/06/2006 | CN1829734A Peptides capable of binding to titanium, silver and silicone |
| 09/06/2006 | CN1829523A Viral vectors |
| 09/06/2006 | CN1273189C West nile vaccine |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101700 Peptide vector |
| 09/05/2006 | US7101685 Recombinant Sendai virus |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101554 Picornaviruses, vaccines and diagnostic kits |
| 08/31/2006 | WO2006090933A1 Hepatitis c virus particles and method of proliferating the same |
| 08/31/2006 | WO2006090689A1 Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector |
| 08/31/2006 | WO2005038430A3 Viral fibers |
| 08/31/2006 | US20060194248 Method of measuring human CYP3A inducibility |
| 08/31/2006 | DE19952957B4 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 08/31/2006 | CA2598547A1 Primate t-lymphotropic viruses |
| 08/30/2006 | EP1696031A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 08/30/2006 | EP1694852A2 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
| 08/30/2006 | EP1694831A1 Pathogenic bovine enterovirus, vaccines, and diagnostic methods |
| 08/30/2006 | EP1694830A2 Novel atypical pneumonia-causing virus |
| 08/30/2006 | EP1694829A2 Novel strain of sars-associated coronavirus and applications thereof |
| 08/30/2006 | EP1694828A1 Serum-free vero cell banking process |
| 08/30/2006 | EP1694694A2 Replication competent hepatitis c virus and methods of use |
| 08/30/2006 | EP1694364A2 System for treating and preventing breast cancer |